| HOME >> MEDICINE >> TECHNOLOGY |
$
37,216$
40,533Available-for-sale securities
101,970166,241Inventories
3,225-Prepaid expenses and other assets
1,6484,106Current assets of discontinued operations
612,482Total current assets
144,065223,362Property and equipment, net
221259Non-current assets of discontinued operations
-6,411Total assets
$
44,286$
230,032Current liabilities: Accounts payable
$
2,395$
8,082Accrued and other liabilities
6,3776,769Current liabilities of discontinued operations
3,5127,659Total current liabilities
12,28422,510Notes payable-net of current portion
-15,255Non-current liabilities of discontinued operations
-5,541Total liabilities
12,28443,306Commitments and contingenciesStockholders' equity: Common stock; $.001 par value; shares authorized 200,000; shares outstanding - 81,568 at December 31, 2010; 80,607 at December 31, 2009, respectively
8281Additional paid-in capital
432,041420,708Accumulated other comprehensive income (loss)
4(3)Accumulated deficit
(300,125)(234,060)Total stockholders' equity
132,002186,726Total liabilities and stockholders' equity
$
44,286$
230,032*The Condensed Consolidated Balance Sheet at December 31, 2009 has
been derived from the Company's audited financial statements at that date.
'/>"/>
| SOURCE VIVUS, Inc. Copyright©2010 PR Newswire. All rights reserved |